期刊文献+

2型糖尿病并发非酒精性脂肪性肝病发病机制的研究进展 被引量:9

Research Progress on Pathogenesis of Type 2 Diabetic Patients with Non-Alcoholic Fatty Liver Disease
原文传递
导出
摘要 随着2型糖尿病(type 2 diabetes,T2DM)患者人数的不断增加,T2DM已成为现代社会影响人们生活质量的沉重负担。T2DM的主要危害为其慢性并发症,除已知的心脑血管、肾脏、视网膜等病变外,非酒精性脂肪肝(nonalcoholic fatty liver disease,NAFLD)也是其常见并发症之一。T2DM与NAFLD密切相关,非酒精性脂肪性肝炎(nonalcoholic steatohepatitis,NASH)是T2DM患者终末期肝病的最主要原因,并且促进心血管疾病的发生。T2DM和NAFLD相互影响,产生严重后果,因此对二者发病机制的研究也越来越受到重视。本文将就2型糖尿病并发非酒精性脂肪性肝病发病机制的研究进展做一综述。 With the dramatic increasingly of the number of patients with type 2 diabetes (T2DM), T2DM has become a heavy burden on the quality of people's life nowadays. The chronic complications are major hazards for T2DM. NAFLD is another common complication of type 2 diabetes, Non-alcoholic steatohepatitis (NASH) is the main reason of end-stage liver disease in type 2 diabetic Pa- tients, and NASH also promotes the occurrence of cardiovascular disease. T2DM and NAFLD are affected with each other, and lead to serious consequences. At present, more and more attention are played on the pathogenesis of NAFLD and T2DM. This article is aimed to review the research progress on pathogenesis of type 2 diabetic patients with non-alcoholic fatty liver disease.
出处 《现代生物医学进展》 CAS 2013年第7期1389-1391,1388,共4页 Progress in Modern Biomedicine
基金 江苏省淮安市科技局资助项目(HAS2010027)
关键词 2型糖尿病 非酒精性脂肪肝 发病机制 Type 2 diabetes mellitus Nonalcoholic fatty liver disease Pathogenesis
  • 相关文献

参考文献5

二级参考文献79

  • 1Manuel Romero-Gómez.Insulin resistance and hepatitis C[J].World Journal of Gastroenterology,2006,12(44):7075-7080. 被引量:22
  • 2Kamran Qureshi,Gary A Abrams.Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2007,13(26):3540-3553. 被引量:52
  • 3Angulo P.Nonalcoholic fatty liver disease.N Engl J Med 2002; 346:1221-1231.
  • 4Reid AE.Nonalcoholic steatohepatitis.Gastroenterology 2001; 121:710-723.
  • 5Carmeliet P.Angiogenesis in life,disease and medicine.Nature 2005; 438:932-936.
  • 6Kalluri R,Sukhatme VP.Fibrosis and angiogenesis.Curr Opin Nephrol Hypertens 2000; 9:413-418.
  • 7Yoshiji H,Kuriyama S,Yoshii J,Ikenaka Y,Noguchi R,Hicklin DJ,Wu Y,Yanase K,Namisaki T,Yamazaki M,Tsujinoue H,Imazu H,Masaki T,Fukui H.Vascular endothelial growth factor and receptor interaction is a prerequisite for murine hepatic fibrogenesis.2003; 52:1347-1354.
  • 8Medina J,Caveda L,Sanz-Cameno P,Arroyo AG,Martín-Vílchez S,Majano PL,García-Buey L,Sánchez-Madrid F,Moreno-Otero R.Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis.J Hepatol 2003; 38:660-66.
  • 9Kitade M,Yoshiji H,Kojima H,Ikenaka Y,Noguchi R,Kaji K,Yoshii J,Yanase K,Namisaki T,Asada K,Yamazaki M,Tsujimoto T,Akahane T,Uemura M,Fukui H.Leptin-mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats.Hepatology 2006; 44:983-991.
  • 10Kitade M,Yoshiji H,Kojima H,Ikenaka Y,Noguchi R,Kaji K,Yoshii J,Yanase K,Namisaki T,Yamazaki M,Tsujimoto T,Moriya K,Kawaratani H,Akahane T,Fukui H.Neovascularization and oxidative stress in the progression of non-alcoholic steatohepatitis.Mol Med Report 2008; 1:543-548.

共引文献135

同被引文献124

引证文献9

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部